Going concern
Filing comparison
Emergent BioSolutions Inc.'s going-concern disclosure changed
Substantial doubt raised, alleviated by management's plans → Risk-factor language only
We may be unable to continue to progress on or implement our strategic plans and sustain our current operating performance, in which case our business, results of operations, financial condition and prospects could be adversely affected, and which may give rise to substantial doubt regarding our ability to continue as a going concern. As of December 31, 2025, we had unrestricted cash and cash equivalents of $205.4 million and remaining capacity under the Revolving Credit Agreement of $100.0 million. Also as of December 31, 2025, we had borrowings of $150.0 million on our Term Loan Facility…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- risk_factor_only
- Current state label
- Risk-factor language only
- Direction
- eased
- Located in
- risk factors / forward-looking statements only
- Prior filed
- 2025-03-04
- Prior form
- 10-K
- Prior state
- doubt_alleviated
- Prior state label
- Substantial doubt raised, alleviated by management's plans
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.